Clarifying the management of Clostridium difficile infectionBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6130 (Published 19 November 2015) Cite this as: BMJ 2015;351:h6130
- Damian P Mawer, clinical research fellow1,
- Mark H Wilcox, professor of medical microbiology1
- 1Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds LS1 3EX, UK
Spector and Knight highlight the potential role of faecal transplantation in the management of Clostridium difficile infection.1 We agree that prolonged follow-up data are needed, given the unknown long term adverse consequences, but we wish to clarify come of their statements.
Firstly, Spector and Knight quote a recurrence rate of 25% after initial mild infection but recurrence …